Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
700.00    0.00 (0.00%)
Bid:
690.00
Ask:
710.00
Spread: 20.00 (2.899%)
Market Cap: £246.67m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
16th Apr 20254:45 pmRNSSpecial Dividend Declaration
7th Apr 20252:55 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Feb 20257:00 amRNSTrading Statement
14th Feb 20252:58 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSInterim Dividend Declaration
8th Jan 202510:20 amRNSDirector/PDMR Shareholding
6th Jan 202512:00 pmRNSDirector/PDMR Shareholding
12th Dec 20243:18 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSFollow on Investment – XPT Group LLC
12th Nov 20249:36 amRNSDirector/PDMR Shareholding
31st Oct 20245:45 pmRNSCancellation of Shares & Buy-Back Programme Update
30th Oct 20247:00 amRNSNew Investment – SRT & Partners Limited
29th Oct 202412:40 pmRNSFollow on Investment – Pantheon Specialty Group
29th Oct 20249:40 amRNSSale of Lilley Plummer Holdings Limited
23rd Oct 20247:00 amRNSHalf Year Results
14th Oct 20247:00 amRNSNew Investment – Volt UW HoldCo Ltd
11th Oct 202410:10 amRNSTransaction in Own Shares
9th Oct 202410:00 amRNSNotice of HY Results and Investor Presentation
7th Oct 20244:03 pmRNSTransaction in Own Shares
1st Oct 20243:37 pmRNSTransaction in Own Shares
1st Oct 202411:04 amRNSTransaction in Own Shares
30th Sep 20242:20 pmRNSNew Investment – CEE Specialty s.r.o.
30th Sep 20249:00 amRNSTransaction in Own Shares
27th Sep 20241:10 pmRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 202412:05 pmRNSTransaction in Own Shares
19th Sep 20245:02 pmRNSTransaction in Own Shares
18th Sep 20243:15 pmRNSTransaction in Own Shares
18th Sep 20243:00 pmRNSDirector/PDMR Shareholding
17th Sep 20245:00 pmRNSTransaction in Own Shares
17th Sep 20247:02 amRNSTransaction in Own Shares
17th Sep 20247:01 amRNSAppointment of Joint Corporate Broker
17th Sep 20247:00 amRNSTrading Statement
16th Sep 20242:15 pmRNSDirectorate Change
13th Sep 20243:04 pmRNSTransaction in Own Shares
10th Sep 20241:43 pmRNSTransaction in Own Shares
5th Sep 20242:00 pmRNSDirectorate Change
5th Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20245:05 pmRNSTransaction in Own Shares
2nd Sep 202410:09 amRNSTransaction in Own Shares
27th Aug 20243:15 pmRNSTransaction in Own Shares
13th Aug 20249:33 amRNSTransaction in Own Shares
6th Aug 20244:25 pmRNSTransaction in Own Shares
5th Aug 20242:03 pmRNSTransaction in Own Shares
5th Aug 20249:20 amRNSDirector/PDMR Shareholding
2nd Aug 20248:45 amRNSShare Buy-Back Programme Update
23rd Jul 20242:35 pmRNSResult of AGM
19th Jul 20242:32 pmRNSTransaction in Own Shares
18th Jul 202411:19 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.